MRI Contrast Agents Market Analysis

The MRI contrast agents market is segmented based on product into iodinated, gadolinium-based, barium-based, and microbubble, out of which, the iodinated segment is anticipated to grab the largest share by the end of 2030 as it provides remarkable low toxicity and radio-opacity than the other types of contrast agents. Moreover, the microbubble is the fastest growing segment on the back of its improved visualization of blood flow without using radiation. 

On the basis of indication, the neurological segment in the market is expected to hold a major share by recording a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that the rising requirement for MRI contrast agents for the diagnosis of CNS for neurological disorders, as they provide improved and better images of neural structures as compared to other diagnostic devices such as CT scan.

Our in-depth analysis of the global market includes the following segments